AorticLab
Italy - Colleretto GiacosaMedical Devices
Focus: AorticLab develops transcatheter embolic protection devices for cardiovascular applications, specifically targeting aortic valve stenosis. The company is an early-stage medical device innovator based in Italy with a single clinical program.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
SERIES B
Open Jobs
0
About AorticLab
AI assessmentNot HiringNo open roles listed right now. Follow AorticLab to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
FLOWer Embolic Protection System
Aortic Valve StenosisClinical Trials (1)
NCT04704258NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection Device
N/AHelp build intelligence for AorticLab
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.